A global biopharma company with a clear purpose: uniting science, technology and talent to get ahead of disease together.
For over a century, GSK has been at the forefront of medical innovation. Today we focus our R&D on four core therapeutic areas β infectious diseases, HIV, oncology and immunology β powered by cutting-edge immune system science and new platform technologies. Our ambition is to positively impact the health of 2.5 billion people over the next decade.
At GSK, our purpose is clear: to unite science, technology and talent to get ahead of disease together. This isn't just a statement β it's the foundation of everything we do, from the laboratory bench to the patient's bedside.
Our strategy centres on delivering strong growth and improving the health of millions. We focus our investments where we can make the greatest difference: vaccines that prevent disease before it starts, specialty medicines that target the most challenging conditions, and a research pipeline built on the immune system, human genetics and advanced technologies such as artificial intelligence.
We have set an ambitious target to positively impact the health of 2.5 billion people by the end of 2030. To achieve this, we invest significantly in R&D, maintain disciplined capital allocation, and foster a culture of accountability, integrity and continuous improvement.
Our culture is built on four expectations: be ambitious for patients, be accountable for impact, do the right thing and keep it simple. We empower our people to take smart risks, challenge convention and bring their authentic selves to work every day.
With over 100,000 employees in more than 80 countries, GSK is a place where diverse perspectives come together to solve the world's most pressing health challenges. We believe that great science happens when great minds collaborate β and our inclusive workplace is designed to make that possible.
We invest in our people through industry-leading development programmes, competitive rewards and a commitment to wellbeing. At GSK, every individual has the opportunity to make a difference β for patients, for communities, and for each other.
From Burroughs Wellcome to GlaxoSmithKline, over 100 years of breakthroughs in medicine and vaccines.
Operating in 80+ countries with major R&D hubs in the UK, US and Belgium, serving patients worldwide.
Ranked 2nd globally in the Access to Medicine Index, leading the industry in health equity and sustainability.